The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Tenenbaum, Julie ^a,b   Ayoub, Mohammed A ^a,b   Perkovska, Sanja ^a,b   Adra Delenne, Anne Laure ^a,b   Mendre, Christiane ^a,b   Ranchin, Bruno ^c   Bricca, Giamperro ^c   Geelen, Ghislaine ^d   Mouillac, Bernard ^a,b   Durroux, Thierry ^a,b   Morin, Denis ^a,b,e  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; GUANINE NUCLEOTIDE BINDING PROTEIN; VASOPRESSIN V2 RECEPTOR;

ANTIDIURESIS; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY DISEASE; MOLECULAR MECHANICS; MUTANT; NEPHROGENIC SYNDROME OF INAPPROPRIATE DIURESIS; RECEPTOR BINDING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; CERCOPITHECUS AETHIOPS; COS CELLS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; INAPPROPRIATE ADH SYNDROME; MUTANT PROTEINS; PROTEIN BINDING; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 77949508275     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008383     Document Type: Article

References (19)

1. Thompson MD, Percy ME, McIntyre Burnham W, Cole DE (2008) G protein- coupled receptors disrupted in human genetic disease. Methods Mol Biol 448: 109-137.
2. Bichet DG (2006) Nephrogenic diabetes insipidus. Adv Chronic Kidney Dis 13: 96-104.
3. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, et al. (2005) Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352: 1884-1890.
4. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, et al. (2007) Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18: 606-612.
5. Marcialis MA, Faa V, Fanos V, Puddu M, Pintus MC, et al. (2008) Neonatal onset of nephrogenic syndrome of inappropriate antidiuresis. Pediatr Nephrol 23: 2267-2271.
6. Soule S, Florkowski C, Potter H, Pattison D, Swan M, et al. (2008) Intermittent severe, symptomatic hyponatraemia due to the nephrogenic syndrome of inappropriate antidiuresis. Ann Clin Biochem 45: 520-523.
7. Bes DF, Mendilaharzu H, Fenwick RG, Arrizurieta E (2007) Hyponatremia resulting from arginine vasopressin receptor 2 gene mutation. Pediatr Nephrol 22: 463-466.
8. Gupta S, Cheetham T, Roberts C, Bourn D, Coulthard M, et al. (2009) Thirst perception and AVP production in a kindred with an activating mutation of the type 2 Vasopressin receptor. The pathophysiology of Nephrogenic Syndrome of Antidiuresis (NSIAD). Eur J Endocrinol.
9. Charest PG, Terrillon S, Bouvier M (2005) Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep 6: 334-340.
10. Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta- arrestins. Science 308: 512-517.
11. Shenoy SK, Lefkowitz RJ (2005) Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE 2005: cm10.
12. Morin D, Cotte N, Balestre MN, Mouillac B, Manning M, et al. (1998) The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett 441: 470-475.
13. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG (1999) Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 274: 32248-32257.
14. Pfleger KD, Seeber RM, Eidne KA (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1: 337-345.
15. Ayoub MA, Maurel D, Binet V, Fink M, Prezeau L, et al. (2007) Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharmacol 71: 1329-1340.
16. Kocan M, See HB, Sampaio NG, Eidne KA, Feldman BJ, et al. (2009) Agonist- independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis. Mol Endocrinol 23: 559-571.
17. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, et al. (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455: 497-502.
18. Orcel H, Albizu L, Perkovska S, Durroux T, Mendre C, et al. (2009) Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane. Mol Pharmacol 75: 637-647.
19. Morin D, Ala Y, Sabatier N, Cotte N, Hendy G, et al. (1998) Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H. Adv Exp Med Biol 449: 391-393.